Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A role for mammalian target of rapamycin in regulating T cell activation versus anergy.

A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Abstract Text:

    yan zhengYan Zheng,samuel l collinsSamuel L Collins,michael a lutzMichael A Lutz,amy n allenAmy N Allen,thomas p koleThomas P Kole,paul e zarekPaul E Zarek,jonathan d powellJonathan D Powell,

    Whether TCR engagement leads to activation or tolerance is determined by the concomitant delivery of multiple accessory signals, cytokines, and environmental cues. In this study, we demonstrate that the mammalian target of rapamycin (mTOR) integrates these signals and determines the outcome of TCR engagement with regard to activation or anergy. In vitro, Ag recognition in the setting of mTOR activation leads to full immune responses, whereas recognition in the setting of mTOR inhibition results in anergy. Full T cell activation is associated with an increase in the phosphorylation of the downstream mTOR target S6 kinase 1 at Thr(421)/Ser(424) and an increase in the mTOR-dependent cell surface expression of transferrin receptor (CD71). Alternatively, the induction of anergy results in markedly less S6 kinase 1 Thr(421)/Ser(424) phosphorylation and CD71 surface expression. Likewise, the reversal of anergy is associated not with proliferation, but rather the specific activation of mTOR. Importantly, T cells engineered to express a rapamycin-resistant mTOR construct are resistant to anergy induction caused by rapamycin. In vivo, mTOR inhibition promotes T cell anergy under conditions that would normally induce priming. Furthermore, by examining CD71 surface expression, we are able to distinguish and differentially isolate anergic and activated T cells in vivo. Overall, our data suggest that by integrating environmental cues, mTOR plays a central role in determining the outcome of Ag recognition.

    A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Publishing Authors By Initials

    y zhengY Zheng,sl collinsSL Collins,ma lutzMA Lutz,an allenAN Allen,tp koleTP Kole,pe zarekPE Zarek,jd powellJD Powell,

    For similar cells: blood cells: leukocytes: leukocytes, mononuclear: lymphocytes: t-lymphocytes research abstracts see: cells: blood cells: leukocytes: leukocytes, mononuclear: lymphocytes: t-lymphocytes research

    PUBMED ID PMID:

    MEDLINE DATE:

    A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    VOLUME: 178

    Page Numbers: 2163-70

    Journal Abbreviation: J. Immunol.

    ISSN: 0022-1767

    DAY: 15

    MONTH: Feb

    YEAR: 2007

    A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2985117

    A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Keywords Mesh Terms:

    KEYWORDS: T-Lymphocytes

    MESH TERMS: immunology

    Chemical & Substance for Abstract: A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Information

    Substance Name: Ribosomal Protein S6 Kinases

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for A role for mammalian target of rapamycin in regulating T cell activation versus anergy.

    AFFILIATION: The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Medical Institutions, Baltimore, MD 21231, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01CA98109

    ACRONYM: CA

    MEDLINETA: J Immunol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A role for mammalian target of rapamycin in regulating T cell activation versus anergy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News